The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Helix Biopharma Corp closed at $1.55.

Over the last five days, shares have lost 6.06% and are down 22.50% for the last year to date. This security has underperformed the S&P TSX by 31.49% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated at previous session's close. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJul 31, 201607/31/2016Apr 30, 201604/30/2016Jan 31, 201601/31/2016Oct 31, 201510/31/2015
Revenue--0----
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3223
Selling / general / administrative1111
Research & development2111
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-3-2-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-2-2-3
Income after tax-3-2-2-3
Income tax, total--------
Net income-3-2-2-3
Total adjustments to net income--------
Net income before extra. items-3-2-2-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-2-2-3
Inc. avail. to common incl. extra. items-3-2-2-3
Diluted net income-3-2-2-3
Dilution adjustment--------
Diluted weighted average shares88858585
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.03-0.03-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.03-0.03-0.03